Sechium edule (Cucurbitaceae) Chayote, Squash Pear, Lanku, Chocho, ChowChow, False Potato

Das K
3 hours ago
16 min read

Sechium edule, commonly known as chayote, is a remarkable edible and medicinal plant, deeply valued in traditional medicine systems across Mesoamerica, Asia, and Africa for its broad-spectrum therapeutic applications. It is most notably recognized as a potent antihypertensive, antidiabetic, anti-inflammatory, and nephroprotective agent. The plant exhibits a diverse pharmacological profile, demonstrating significant activity against kidney stones, cardiovascular diseases, and various inflammatory conditions. Cutting-edge modern research has validated its traditional uses, revealing that specific inedible hybrids possess up to one thousand times greater antineoplastic activity than edible varieties, with 2025 studies providing novel pharmacokinetic data for key metabolites like cucurbitacin B and establishing detailed phytochemical profiles.

---

1. Taxonomic Insights

Species: Sechium edule (Jacq.) Sw.

Family: Cucurbitaceae

Taxonomic Note: The plant was first described by Nikolaus Joseph von Jacquin and later reclassified by the Swedish botanist Olof Swartz. The genus name Sechium is derived from the Greek word for cucumber, while the specific epithet edule means edible. The plant is known by its synonym Sechium americanum Poir.

The Cucurbitaceae family, commonly known as the gourd or squash family, comprises approximately 965 species across 95 genera of flowering plants. It is characterized by tendril-bearing vines, palmately veined leaves, and fleshy fruits called pepos. This family is medicinally and economically significant, containing well-known plants like pumpkin, cucumber, and bitter melon.

Related Herbs from the Same Family:

· Cucurbita pepo (Pumpkin): Valued for its seeds' anthelmintic and prostate health properties.

· Momordica charantia (Bitter Melon/Karela): Renowned globally for its potent antidiabetic and hypolipidemic properties.

· Citrullus lanatus (Watermelon): The seeds and rind have diuretic and antihypertensive applications.

· Cucumis sativus (Cucumber): Prized for its cooling, diuretic, and skin-soothing properties.

---

2. Common Names

---

3. Medicinal Uses

Primary Actions: Antihypertensive, Antidiabetic, Anti-inflammatory, Nephroprotective, Hepatoprotective, Antioxidant, Antiepileptic, CNS Depressant.

Secondary Actions: Diuretic, Cardioprotective, Antiulcer, Antimicrobial, Antiproliferative (anticancer), Antigenotoxic, Hypolipidemic.

Medicinal Parts:

Almost every part of the plant the fruit, leaves, stems, roots, and seeds is used medicinally, with varying concentrations of bioactive compounds.

· Fruits: The most commonly used part, employed for hypertension, diabetes, kidney stones, and as a diuretic. Edible varieties contain lower levels of cucurbitacins, while non-edible hybrids are being studied for anticancer applications.

· Leaves: Used as a diuretic, to dissolve kidney stones, and for arteriosclerosis and hypertension. Leaf decoctions are also used to relieve urine retention and burning sensation during urination.

· Roots: The tuberous roots are typically considered a medicinal part and used in traditional preparations.

· Seeds: Contain gibberellins and other bioactive compounds.

· Stems: Used in traditional medicine for various applications.

---

4. Phytochemicals Specific to the Plant and Their Action

Quantitative Profile (2020 Hybrid Study): The hybrid H387 07 extract contained total phenolic compounds of 36.18 mg gallic acid equivalents per gram of extract. Galangin was the most abundant flavonoid at 21.94 mg/g extract, followed by phloretin at 4.616 mg/g, naringenin at 3.304 mg/g, and chlorogenic acid at 4.224 mg/g. The edible parent variety only contains four flavonoids and six phenolic acids, while the hybrid contains eight flavonoids and eight phenolic acids.

Major Bioactive Compounds:

· Cucurbitacins (B, D, E, I, IIA): These highly oxygenated tetracyclic triterpenoids are among the most bioactive compounds in S. edule and are characteristic of the Cucurbitaceae family. They exhibit Anti-inflammatory, Anticancer (inducing autophagy and apoptosis), Hepatoprotective, Antimicrobial, Antiviral, Antihyperglycemic, and Cardioprotective activities. A 2025 pharmacokinetic study documented cucurbitacin IIA in plasma for the first time, and cucurbitacin B showed Cmax of 37.56 µg/mL at 1 hour post-dose after oral administration of 125 mg/kg, confirming rapid absorption and systemic distribution.

· Flavonoids (Galangin, Naringenin, Phloretin, Apigenin, Quercetin, Myricetin, Rutin, Kaempferol derivatives): These provide Antioxidant, Anti-inflammatory, Hepatoprotective, and Anticancer properties. Galangin increased from zero in the parent to 22 mg/g of extract in the hybrid H387 07.

· Phenolic Acids (Chlorogenic acid, Caffeic acid, Gallic acid, Ferulic acid, p-Coumaric acid, Vanillic acid): These contribute to Antioxidant, Anti-inflammatory, and Cytoprotective effects. Chlorogenic acid increased from 0.823 mg/g in the parent to 4.224 mg/g in the hybrid.

· C-glycosyl Flavones (Vitexin, Isovitexin, Orientin, Isoorientin): Characteristic compounds of the species with documented antioxidant and anti-inflammatory activities.

· Saponins (Steroidal and Triterpenoid variants): Present across the plant, providing Immunomodulatory, Antifungal, and Cholesterol-lowering properties.

· Gibberellins (GA3, GA4, and others): Plant hormones found in the seeds with potential biological activities.

· Essential Amino Acids and Minerals: The plant contains all essential amino acids and significant levels of potassium (125-175 mg/100g), calcium (12-17 mg/100g), phosphorus (18-27 mg/100g), and magnesium (12-16 mg/100g).

· Carotenoids (β-carotene, Lutein, Zeaxanthin): Contributing to antioxidant properties.

---

5. Traditional and Ethnobotanical Uses Covering the Medicinal Uses

Raktachapa (Hypertension) & Hridroga (Cardiovascular Diseases)

Formulation: Fruit juice; leaf decoction.

Preparation & Use: Chayote is widely used to lower blood pressure. In traditional systems across Mexico, Central America, and Asia, the fruit is consumed regularly or taken as juice for hypertension. Leaves are used for arteriosclerosis.

Reasoning: The high potassium content (125-175 mg/100g) helps counteract sodium and lower blood pressure. Flavonoids also contribute to vasodilation. Clinical intervention studies in older adults with metabolic syndrome showed that daily supplementation with Sechium edule powder for six months resulted in decreased blood pressure along with reduced lipoperoxides and HbA1c.

Madhumeha (Diabetes Mellitus) & Pancreatic Protection

Formulation: Fruit juice; fruit extract.

Preparation & Use: The fruit is traditionally consumed to manage diabetes. In Mexico, chayote juice has been used for generations as a hypoglycemic agent.

Reasoning: Modern research provides robust validation. A 2025 study demonstrated that chayote juice preserves pancreatic islet integrity, maintains insulin secretion, and lowers blood glucose in streptozotocin-induced diabetic mice. The mechanism involves suppression of apoptosis markers including caspase-3 and BAX, downregulation of inflammatory mediators including NF-κB and NLRP3, and enhancement of antioxidant responses via Nrf2 and HO-1 pathways. Molecular docking suggests strong binding of vicenin-2 to KEAP1 and related proteins.

Ashmari (Kidney Stones) & Mutrakrichra (Urinary Disorders)

Formulation: Leaf decoction; fruit juice.

Preparation & Use: Decoctions of leaves or fruits are used as a diuretic and to dissolve kidney stones. The plant is also used to relieve urine retention and burning sensation during urination.

Reasoning: The diuretic properties have been documented in pharmacological studies. The aqueous leaf extract has shown nephroprotective activity, decreasing levels of blood urea, blood urea nitrogen, and serum creatinine in nephrotoxic and diabetic models, while also improving renal histology.

Shotha (Inflammation) & Vata Rakta (Rheumatism)

Formulation: Fruit extract; fruit consumption.

Preparation & Use: The fruit is used for various inflammatory conditions including rheumatism.

Reasoning: The anti-inflammatory effects are well documented. A 2020 study showed that the Sechium hybrid extract reduces levels of tumor necrosis factor alpha, interferon gamma, and interleukin-6 while increasing the anti-inflammatory cytokine interleukin-10 and glutathione peroxidase levels in treated mice. This modulation of the inflammatory cytokine profile provides a scientific basis for its traditional use.

Apasmara (Epilepsy) & Manasika Vikara (CNS Disorders)

Formulation: Ethanol extract of fruits.

Preparation & Use: In traditional medicine, especially in Northeast India, the plant has been used for neurological conditions.

Reasoning: A 2012 pharmacological study provides strong validation for this use. The ethanol extract of fruits at 200 mg/kg body weight significantly reduced the duration of various phases of convulsions in both MES-induced seizures and PTZ-induced convulsions. In CNS depressant models, locomotor activity decreased in a dose-dependent manner, and the rota rod test revealed significant loss of muscular coordination. This confirms antiepileptic and CNS depressant activities.

Amashaya Vrana (Gastric Ulcers)

Formulation: Ethanolic fruit extract.

Preparation & Use: Traditional practitioners use the plant for gastrointestinal complaints including ulcers.

Reasoning: Studies have confirmed antiulcer activity. The ethanolic extract of fruits (100, 300, and 500 mg/kg) significantly reduced the number of gastric petechiae, with inhibition percentages of 25.00%, 52.08%, and 70.83% respectively, comparable to the standard drug ranitidine (100 mg/kg). The extract shows inhibition of gastric fluid volume, free acidity, and total acidity.

Visha Janita Kshata (Oxidative Stress Protection)

Formulation: Fruit juice or powder.

Preparation & Use: Traditional use as a general tonic for overall health maintenance.

Reasoning: The plant exhibits potent antioxidant and antigenotoxic effects. A mouse micronucleus assay demonstrated that chayote juice reduced the frequency of micronucleated erythrocytes induced by benzo[a]pyrene by up to 70%. Clinical intervention in older adults with metabolic syndrome showed decreased lipoperoxides, 8-isoprostanes, and oxidative stress score, alongside elevated superoxide dismutase and total antioxidant status.

---

6. Healing Recipes, Decoctions, and Preparations

Antihypertensive Fruit Juice

Purpose: To help manage high blood pressure.

Preparation & Use:

1. Wash and peel 1-2 fresh chayote fruits.

2. Blend with 250 ml of water until smooth.

3. Strain and drink fresh once daily.

4. Clinical studies have shown benefits with daily supplementation for six months. Use under professional supervision alongside conventional hypertension care.

Antidiabetic Fruit Decoction

Purpose: Supportive therapy for blood sugar management.

Preparation & Use:

1. Take 1-2 fresh chayote fruits, chopped (with or without peel).

2. Simmer in 500 ml of water for 20-30 minutes.

3. Cool and strain. Drink 150-200 ml twice daily.

4. Studies in diabetic models have shown efficacy with 100-200 mg/kg extracts. Use under professional supervision.

Diuretic Leaf Infusion

Purpose: For kidney stones and urinary disorders.

Preparation & Use:

1. Take 5-10 grams of dried Sechium edule leaves or 1-2 fresh leaves.

2. Steep in 250 ml of hot water for 15 minutes.

3. Strain and drink twice daily. Use under professional guidance.

Anti-inflammatory Fruit Powder (for Metabolic Support)

Purpose: For chronic inflammation and metabolic syndrome.

Preparation & Use:

1. Dry chayote fruit slices thoroughly.

2. Grind to a fine powder.

3. Take 1-2 teaspoons daily mixed with water or food.

4. Clinical studies have used powder concentrate for six months showing reductions in inflammatory markers and blood pressure.

---

7. In-Depth Phytochemical Profile and Clinical Significance of Sechium edule (Chayote)

Introduction

Sechium edule, the chayote or vegetable pear, represents a remarkable convergence of food and medicine. Native to Mesoamerica and now cultivated globally across tropical and subtropical regions, this unassuming squash has served as both a dietary staple and a "village pharmacy" for centuries. Its deep integration into traditional medicine systems from Mexico to India and from China to Indonesia is now being illuminated by cutting-edge pharmacological research. The plant's therapeutic potency resides in a diverse and sophisticated phytochemical arsenal, dominated by cucurbitacins, flavonoids, phenolic acids, and essential minerals. Recent breakthroughs from 2020, 2024, and 2025 have placed it at the forefront of medicinal plant research. A 2020 study revealed that a specific inedible hybrid, H387 07, contains up to 16 polyphenolic compounds including galangin at 21.94 mg/g extract, with antineoplastic activity one thousand times greater than edible varieties. A 2024 study using molecular docking and animal models elucidated the pancreatic protective mechanisms of chayote juice, demonstrating preservation of islet integrity and modulation of Nrf2/HO-1 pathways. A 2025 pharmacokinetic study provided the first ever data on the absorption, distribution, and elimination of key metabolites including cucurbitacins B, E, I, and IIA, with cucurbitacin IIA documented in plasma for the first time. Sechium edule stands as a powerful testament to the potential of natural products to yield clinically relevant therapeutics.

1. Cucurbitacins: The Signature Anticancer and Anti-inflammatory Arsenal

Key Compounds: Cucurbitacin B (CuB), Cucurbitacin D, Cucurbitacin E, Cucurbitacin I, Cucurbitacin IIA (CuIIA).

Quantitative Profile (2025 Pharmacokinetic Study): Following oral administration of 125 mg/kg of the H387 07 hybrid extract in mice, cucurbitacin B exhibited a maximum plasma concentration (Cmax) of 37.56 µg/mL at 1 hour post-dose, confirming rapid absorption and systemic distribution. The half-life (T1/2) and volume of distribution (Vd) were also determined, though specific values vary by compound.

Actions and Clinical Relevance:

· Anticancer (Potent and Selective): Cucurbitacins are the most studied anticancer compounds in the Cucurbitaceae family. Their mechanisms include inducing autophagy (cellular self-digestion), promoting apoptosis (programmed cell death), and inhibiting cell proliferation. The Sechium hybrid H387 07 has shown the ability to induce apoptosis in murine leukemia cell lines P388 (macrophagic) and J774 (monocytic) and the myelomonocytic leukemia cell line WEHI-3. Significantly, the hybrid extract is one thousand times more active in inhibiting tumor cells than the edible variety, with none of the varieties damaging normal cells.

· Anti-inflammatory: Cucurbitacins inhibit multiple inflammatory pathways. The Sechium hybrid extract has been shown to reduce levels of pro-inflammatory cytokines TNFα, IFNγ, and IL-6 while increasing the anti-inflammatory cytokine IL-10 in treated mice.

· Pharmacokinetic Breakthrough (2025): The 2025 study provided, for the first time, a comprehensive pharmacokinetic profile of Sechium secondary metabolites after oral administration. The presence of CuIIA in plasma was documented for the first time. These findings are critical for understanding the therapeutic potential of the hybrid and for advancing natural product-based drug development.

2. Flavonoids and Phenolic Compounds: The Antioxidant and Anti-inflammatory Matrix

Key Compounds: Galangin, Naringenin, Phloretin, Apigenin, Quercetin, Myricetin, Rutin, Chlorogenic acid, Caffeic acid, Gallic acid.

Quantitative Profile (2020 Hybrid Study): The hybrid H387 07 contains significantly higher levels of flavonoids and phenolic acids compared to its edible parent. Total phenolic content was 36.18 mg GAE/g extract. Flavonoid concentrations were galangin 21.94 mg/g, phloretin 4.616 mg/g, naringenin 3.304 mg/g, apigenin 0.362 mg/g, and rutin 1.273 mg/g extract. The hybrid contains eight flavonoids and eight phenolic acids, while the edible parent contains only four and six respectively.

Actions and Clinical Relevance:

· Antioxidant (Potent and Synergistic): The hybrid extract demonstrated significant free radical scavenging activity. The DPPH inhibition IC50 was 0.88 ± 0.018 mg/mL, with approximately 70% inhibition achieved at 1.5 mg/mL extract. A high correlation was found between antioxidant activity and phenolic compound content, with a Pearson correlation of 0.995.

· Membrane Protection: The extract protected dimyristoylphosphatidylethanolamine (DMPE) phospholipid model cell membranes from oxidation mediated by hypochlorous acid (HClO), demonstrating its ability to preserve cellular membrane integrity under oxidative stress.

· Bioavailability Confirmed: The most abundant phenolic compounds in the hybrid extract, including galangin, were shown to enter the bloodstream of treated mice, confirming their systemic bioavailability and potential for therapeutic action.

3. Antidiabetic and Pancreatic Protective Mechanisms (2024 Breakthrough)

Key Study: A 2024 study explored the protective mechanisms of chayote juice in mitigating streptozotocin-induced pancreatic dysfunction in a mouse model and H2O2-treated MIN-6 insulinoma cells.

Mechanisms Elucidated:

· Preservation of Pancreatic Islet Integrity: Chayote juice protected the structure and function of pancreatic islets, which are responsible for insulin production, in diabetic mice.

· Suppression of Apoptosis: The treatment reduced apoptosis markers including caspase-3 and BAX, preventing the programmed cell death of insulin-producing beta cells.

· Downregulation of Inflammation: The extract reduced inflammatory mediators including NF-κB and NLRP3, key drivers of pancreatic inflammation in diabetes.

· Enhancement of Antioxidant Responses: Chayote juice enhanced antioxidant defenses via upregulation of Nrf2 (nuclear factor erythroid 2-related factor 2) and HO-1 (heme oxygenase-1) pathways.

· Molecular Docking: In silico studies suggested strong binding of the flavonoid vicenin-2 to KEAP1 and related proteins, providing insight into the extract's cellular targets at the molecular level.

· In Vivo Efficacy: The treatment preserved insulin secretion and lowered blood glucose in the diabetic mouse model, confirming the therapeutic relevance of these mechanisms.

4. Antihypertensive and Metabolic Syndrome Clinical Evidence

Key Clinical Study: A clinical intervention in older adults with metabolic syndrome demonstrated that daily supplementation with Sechium edule powder concentrate for six months resulted in:

· Decreased lipoperoxides (TBARS) and 8-isoprostanes, markers of oxidative damage.

· Reduced HbA1c, a long-term marker of blood glucose control.

· Elevated superoxide dismutase (SOD) and total antioxidant status, indicating enhanced endogenous antioxidant defenses.

· Increased anti-inflammatory interleukin-10 (IL-10).

· Reduced blood pressure (both systolic and diastolic).

· Decreased diagnostic criteria for metabolic syndrome.

Mechanisms: The antihypertensive effect is attributed to the high potassium content (125-175 mg/100g) which counteracts sodium, along with the vasodilatory effects of flavonoids. The metabolic benefits derive from the combined antioxidant, anti-inflammatory, and insulin-sensitizing actions of the diverse polyphenolic compounds.

5. Antiepileptic and CNS Depressant Activity (Validated 2012 Study)

Key Study: A 2012 pharmacological study evaluated the ethanol extract of S. edule fruits in rats.

Quantified Efficacy:

· MES-Induced Seizures (200 mg/kg): Flexion phase reduced from 6.00 sec to 2.00 sec, extension phase from 15.16 sec to 8.83 sec, clonus phase from 17.5 sec to 10.83 sec, stupor phase from 94.50 sec to 68.66 sec, and recovery time from 125.16 sec to 76.5 sec.

· PTZ-Induced Seizures (200 mg/kg): Onset time for jerks increased from 51.50 sec to 75.16 sec, clonus from 79.16 sec to 99.16 sec, and extensor from 254.00 sec to 308.00 sec. All treated animals recovered while control animals experienced mortality.

· Locomotor Activity (200 mg/kg): Score reduced from 293.66 to 102.00, a 65.26% reduction in spontaneous motor activity.

· Muscular Coordination (200 mg/kg): Time of fall on rota rod reduced from 312.50 sec to 104.33 sec, a 64.74% loss of coordination, comparable to the standard drug diazepam (94.40%).

Significance: This study provides robust validation for the traditional use of S. edule in neurological and psychiatric conditions, demonstrating both anticonvulsant and CNS depressant properties.

6. Nephroprotective and Hepatoprotective Activities

Nephroprotective Activity: The aqueous extract of leaves at 200 mg/kg has been shown to lower serum creatinine, urea, and uric acid, increase total protein, and improve renal histology in nephrotoxic and diabetic models. The extract also protects against gentamicin and potassium dichromate-induced nephrotoxicity.

Hepatoprotective Activity: The ethanolic extract of fruits significantly reduces the levels of AST, ALT, ALP, total bilirubin, and hepatic lipid peroxidation, protecting liver cells from carbon tetrachloride (CCl4)-induced hepatotoxicity in rats.

7. Antiulcer Activity (Validated)

Quantified Efficacy: In albino rat models with pylorus ligation and ethanol-induced ulcers, ethanolic extracts of Sechium edule fruit at 100, 300, and 500 mg/kg significantly reduced the number of gastric petechiae, with inhibition percentages of 25.00%, 52.08%, and 70.83% respectively. These results demonstrate a gastroprotective effect comparable to that of the standard drug ranitidine at 100 mg/kg (70.83% inhibition). The extract inhibited gastric fluid volume, free acidity, and total acidity.

8. Antimicrobial Activity

Documented Efficacy: Extracts of S. edule inhibit the growth of multiple human pathogens including Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa, and Escherichia coli. The ethyl acetate extract was the most active, an effect attributed to its phenol, flavonoid, and terpenoid content.

An Integrated View of Healing in Sechium edule

· For Metabolic Syndrome (Diabetes, Hypertension, Inflammation): Sechium edule offers a sophisticated, multi-target approach to metabolic health. The 2024 pancreatic protection study demonstrates that chayote juice preserves insulin secretion by protecting beta cells from apoptosis, reducing inflammation via NF-κB and NLRP3 suppression, and enhancing antioxidant responses through Nrf2/HO-1 pathways. Concurrently, the antihypertensive effect is mediated by high potassium content and flavonoid-induced vasodilation, while the anti-inflammatory profile reduces low-grade systemic inflammation. The six-month clinical trial in older adults confirms all these benefits in human subjects, showing reduced blood pressure, HbA1c, oxidative stress markers, and inflammation alongside elevated antioxidant status. This holistic action addresses the interconnected pathologies of metabolic syndrome simultaneously.

· For Cancer Support and Antineoplastic Therapy: The discovery of the H387 07 hybrid with one thousand times greater antineoplastic activity than edible varieties, coupled with its selective cytotoxicity that spares normal cells, represents a paradigm shift in natural product oncology. The 2025 pharmacokinetic study now confirms that key cucurbitacins (B, IIA, E, I) are rapidly absorbed and systemically distributed after oral administration, with cucurbitacin B reaching Cmax of 37.56 µg/mL at 1 hour post-dose. The mechanisms involving autophagy induction, apoptosis promotion, and proliferation inhibition make cucurbitacins valuable leads for drug development. The absence of damage to normal cells addresses a critical limitation of conventional chemotherapy.

· For Neurological Disorders (Epilepsy and CNS Depressant Applications): The 2012 validation of antiepileptic and CNS depressant activity provides a scientific basis for traditional use. The 200 mg/kg dose significantly reduced all phases of MES-induced seizures and delayed PTZ-induced convulsions, with all treated animals recovering while controls died. The 65% reduction in locomotor activity and 65% loss of muscular coordination confirm CNS depressant effects. The precise mechanisms require further study but likely involve GABAergic modulation.

· For Renal and Urinary Health: The nephroprotective effects documented in multiple models (gentamicin, potassium dichromate, streptozotocin-induced nephropathy) support traditional use for kidney stones and urinary disorders. The reduction in serum creatinine, urea, and uric acid, along with improved renal histology, indicates protection against diverse nephrotoxic insults. The diuretic action further supports the elimination of renal calculi.

· For Gastrointestinal Health: The antiulcer activity demonstrating 70.83% inhibition of gastric lesions, comparable to ranitidine, validates traditional use for gastric ulcers. The mechanisms include reduction of gastric acid secretion, protection of mucosal epithelium, and anti-inflammatory action.

Toxicological Profile and Quality Control

Safety Profile of Edible Variety: The edible variety of Sechium edule has a long history of safe dietary consumption and is generally recognized as safe.

Safety Profile of Hybrid H387 07: The hybrid was developed through breeding programs and its inedibility is mainly attributed to the accumulation of secondary metabolites, particularly cucurbitacins, which impart intense bitterness. The 2025 pharmacokinetic study administered doses of 8, 125, and 250 mg/kg orally in mice without reported acute toxicity, though comprehensive toxicological studies are ongoing.

Genotype-Environment Interactions: Genotype-environment interactions appear to be a major driver of variability in secondary metabolite content in S. edule. This underscores the importance of standardized cultivation and extraction protocols for therapeutic applications.

Standardization Parameters: The identification of specific compounds including galangin, naringenin, phloretin, chlorogenic acid, and cucurbitacins B, D, E, I, and IIA provides clear targets for quality control and standardization of therapeutic extracts.

Conclusion: Sechium edule has undergone a remarkable transformation from a traditional food and medicinal plant to a subject of cutting-edge pharmacological research. The 2020 discovery of the H387 07 hybrid with one thousand times greater anticancer activity than edible varieties, the 2024 elucidation of its pancreatic protective mechanisms via Nrf2/HO-1 pathways, the 2025 pharmacokinetic profiling of cucurbitacins documenting their rapid absorption and systemic distribution, and the consistent validation of its antihypertensive, antidiabetic, anti-inflammatory, and neuroprotective properties in clinical and animal studies collectively position Sechium edule as a plant of immense therapeutic potential. It stands as a bridge between ancient wisdom and modern evidence-based medicine, offering validated applications in metabolic syndrome, oncology, neurology, nephrology, and gastroenterology. The identification of specific bioactive compounds, their molecular targets, and their pharmacokinetic parameters opens clear avenues for the development of standardized phytomedicines and novel drug leads.

---

Disclaimer:

Sechium edule is generally recognized as safe based on extensive traditional use as a food and medicine. The edible varieties have an excellent safety profile. The inedible hybrid H387 07 is for research purposes only and not for human consumption. Pregnant and breastfeeding women should consult a healthcare provider before therapeutic use of concentrated extracts. Individuals with diabetes or hypertension should use under professional supervision, as the hypoglycemic and hypotensive effects may interact with medications. Always consult a qualified healthcare professional before using this plant for medicinal purposes. This information is for educational use only and is not a substitute for professional medical advice.

---

8. Reference Books, Books for In-depth Study:

· Indian Medicinal Plants: An Illustrated Dictionary by C.P. Khare

· The Ayurvedic Pharmacopoeia of India (Relevant Volumes)

· Medicinal Plants of the World by Ben-Erik van Wyk and Michael Wink

· PROTA (Plant Resources of Tropical Africa) database resources

· Cucurbits: Medicinal and Economic Importance by various authors

---

9. Further Study: Plants That Might Interest You Due to Similar Medicinal Properties

1. Momordica charantia (Bitter Melon/Karela)

· Species: Momordica charantia | Family: Cucurbitaceae

· Similarities: Sharing the same family, both plants are globally renowned for their potent antidiabetic properties. Bitter melon is more intensely bitter and has stronger immediate hypoglycemic effects through charantin and polypeptide-p, while chayote offers broader metabolic and cardiovascular benefits including antihypertensive and nephroprotective actions.

2. Cucurbita ficifolia (Fig-leaf Gourd/Malabar Gourd)

· Species: Cucurbita ficifolia | Family: Cucurbitaceae

· Similarities: This Cucurbita species shares with chayote a traditional use for diabetes in Mexican traditional medicine, where both are used to prepare aguas frescas (cooling beverages) for blood sugar management. Both are rich in D-chiro-inositol and other hypoglycemic compounds.

3. Phyllanthus niruri (Bhumi Amla)

· Species: Phyllanthus niruri | Family: Phyllanthaceae

· Similarities: While from a different family, Bhumi Amla shares with chayote a primary reputation for dissolving kidney stones and protecting renal function. Both are used extensively for urolithiasis and as diuretics, with nephroprotective mechanisms validated in modern research.

4. Terminalia arjuna (Arjuna)

· Species: Terminalia arjuna | Family: Combretaceae

· Similarities: Arjuna shares with chayote a primary reputation as a cardioprotective and antihypertensive agent. Both are used extensively for cardiovascular health, though Arjuna is more specific for heart muscle function (cardiac tonic) while chayote offers broader metabolic benefits.

-x-x-x-End-x-x-x-

PREHEALING

Sechium edule (Cucurbitaceae) Chayote, Squash Pear, Lanku, Chocho, ChowChow, False Potato

Recent Posts